Literature DB >> 6833457

Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture.

W B Malarkey, M Kennedy, L E Allred, G Milo.   

Abstract

There is only indirect evidence at present to suggest a role for PRL in either the genesis or progression of human breast cancer. Here, we report the results of experiments in primary cultures of breast tumor cells from a hyperprolactinemic breast cancer patient who had an elevated mean 24-h PRL concentration but a normal diurnal variation of PRL release. The effects of PRL and GH on the growth of the dispersed cells from the breast tumor was evaluated in monolayer culture using a recently developed microculture technique. Pharmacological quantities of GH produced significant increases in the number of population doublings of the breast tumor cells. Also, PRL concentrations present in the patient's circulation were demonstrated to significantly increase the number of population doublings of the breast tumor cells obtained in primary cultures. Thus, physiological concentrations of PRL stimulated the growth of breast tumor cells from this premenopausal patient.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833457     DOI: 10.1210/jcem-56-4-673

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Molecular Events as Targets of Anticancer Drug Therapy.

Authors:  Adorján Aszalós; Sándor Eckhardt
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

2.  Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer.

Authors:  A Manni; A E Boucher; L M Demers; H A Harvey; A Lipton; M A Simmonds; M Bartholomew
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

3.  Prolactin regulates mammary epithelial cell proliferation via autocrine/paracrine mechanism.

Authors:  Mathew J Naylor; Jason A Lockefeer; Nelson D Horseman; Christopher J Ormandy
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

Review 4.  Prolactin as a mitogen in mammary cells.

Authors:  R Das; B K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

Review 5.  Prolactin as an autocrine/paracrine factor in breast tissue.

Authors:  C V Clevenger; T L Plank
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

Review 6.  Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the 'cerebral diabetes paradigm'.

Authors:  Janet K Brewer
Journal:  J Mol Neurosci       Date:  2008-06-18       Impact factor: 3.444

7.  Autocrine prolactin: an emerging market for homegrown (prolactin) despite the imports.

Authors:  Senthil K Muthuswamy
Journal:  Genes Dev       Date:  2012-10-15       Impact factor: 11.361

8.  Characterization of prolactin receptors in human breast cancer.

Authors:  J P Peyrat; J Djiane; P A Kelly; B Vandewalle; J Bonneterre; A Demaille
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

9.  Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop.

Authors:  C V Clevenger; W P Chang; W Ngo; T L Pasha; K T Montone; J E Tomaszewski
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

10.  Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.

Authors:  M Bontenbal; J A Foekens; S W Lamberts; F H de Jong; W L van Putten; H J Braun; J T Burghouts; G H van der Linden; J G Klijn
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.